Abstract
In recent years, the connection between APOBEC3 cytosine deaminases and cancer mutagenesis has become ever more apparent. This growing awareness and lack of inhibitory drugs has created a distinct need for biochemical tools that can be used to identify and characterize potential inhibitors of this family of enzymes. In response to this challenge, we have developed a Real-time APOBEC3-mediated DNA Deamination (RADD) assay. The RADD assay provides a rapid, real-time fluorescence readout of APOBEC3 DNA deamination and serves as a crucial addition to the existing APOBEC3 biochemical and cellular toolkit. This method improves upon contemporary DNA deamination assays by offering a more rapid and quantifiable readout as well as providing a platform that is readily adaptable to a high-throughput format for inhibitor discovery. In this chapter we provide a detailed guide for the usage of the RADD assay for the characterization of APOBEC3 enzymes and potential inhibitors.
Original language | English (US) |
---|---|
Title of host publication | Chemical and Genomic Methods in Nucleic Acid Biology |
Editors | Brandt F. Eichman |
Publisher | Academic Press Inc. |
Pages | 311-345 |
Number of pages | 35 |
ISBN (Print) | 9780443297243 |
DOIs | |
State | Published - Jan 2024 |
Publication series
Name | Methods in Enzymology |
---|---|
Volume | 705 |
ISSN (Print) | 0076-6879 |
ISSN (Electronic) | 1557-7988 |
Bibliographical note
Publisher Copyright:© 2024
Keywords
- APOBEC3
- Cancer
- Cytidine deaminase
- Fluorescence resonance energy transfer (FRET)
- High-throughput screening (HTS)
- Real-time assay
- DNA/metabolism
- Enzyme Assays/methods
- Humans
- Cytidine Deaminase/metabolism
- Enzyme Inhibitors/pharmacology
- Fluorescence Resonance Energy Transfer/methods
- Deamination
- APOBEC Deaminases/metabolism
PubMed: MeSH publication types
- Journal Article